Terms: = Pancreatic cancer AND AFF1, MLLT2, 4299, ENSG00000172493, P51825, AF-4, PBM1 AND Treatment
4 results:
1. Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
Tushoski-Alemán GW; Herremans KM; Underwood PW; Akki A; Riner AN; Trevino JG; Han S; Hughes SJ
PLoS One; 2024; 19(2):e0297325. PubMed ID: 38346068
[TBL] [Abstract] [Full Text] [Related]
2. treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.
Walter MA; Nesti C; Spanjol M; Kollár A; Bütikofer L; Gloy VL; Dumont RA; Seiler CA; Christ ER; Radojewski P; Briel M; Kaderli RM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013700. PubMed ID: 34822169
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for pancreatic cancer.
Cerullo M; Gani F; Chen SY; Canner JK; Pawlik TM
World J Surg; 2017 Sep; 41(9):2361-2370. PubMed ID: 28429090
[TBL] [Abstract] [Full Text] [Related]
4. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Bruell D; Stöcker M; Huhn M; Redding N; Küpper M; Schumacher P; Paetz A; Bruns CJ; Haisma HJ; Fischer R; Finnern R; Barth S
Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
[TBL] [Abstract] [Full Text] [Related]
